X4 Pharmaceuticals Inc (XFOR)
0.9085
-0.05
(-5.34%)
USD |
NASDAQ |
May 17, 15:10
X4 Pharmaceuticals Price to Book Value: 147.27 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 155.57 |
| May 15, 2024 | 158.24 |
| May 14, 2024 | 159.74 |
| May 13, 2024 | 158.31 |
| May 10, 2024 | 170.21 |
| May 09, 2024 | 172.64 |
| May 08, 2024 | 168.59 |
| May 07, 2024 | 176.69 |
| May 06, 2024 | 194.52 |
| May 03, 2024 | 186.42 |
| May 02, 2024 | 175.07 |
| May 01, 2024 | 179.12 |
| April 30, 2024 | 181.55 |
| April 29, 2024 | 176.69 |
| April 26, 2024 | 188.85 |
| April 25, 2024 | 183.18 |
| April 24, 2024 | 209.11 |
| April 23, 2024 | 199.39 |
| April 22, 2024 | 220.46 |
| April 19, 2024 | 204.25 |
| April 18, 2024 | 194.52 |
| April 17, 2024 | 193.71 |
| April 16, 2024 | 213.97 |
| April 15, 2024 | 202.63 |
| April 12, 2024 | 217.22 |
| Date | Value |
|---|---|
| April 11, 2024 | 200.20 |
| April 10, 2024 | 197.76 |
| April 09, 2024 | 205.87 |
| April 08, 2024 | 209.11 |
| April 05, 2024 | 222.08 |
| April 04, 2024 | 238.29 |
| April 03, 2024 | 238.29 |
| April 02, 2024 | 223.70 |
| April 01, 2024 | 228.56 |
| March 28, 2024 | 4.568 |
| March 27, 2024 | 4.634 |
| March 26, 2024 | 4.766 |
| March 25, 2024 | 4.798 |
| March 22, 2024 | 4.798 |
| March 21, 2024 | 4.305 |
| March 20, 2024 | 3.352 |
| March 19, 2024 | 3.191 |
| March 18, 2024 | 3.034 |
| March 15, 2024 | 3.039 |
| March 14, 2024 | 2.746 |
| March 13, 2024 | 2.758 |
| March 12, 2024 | 2.835 |
| March 11, 2024 | 2.991 |
| March 08, 2024 | 2.884 |
| March 07, 2024 | 3.004 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5456
Minimum
Jun 29 2022
238.29
Maximum
Apr 03 2024
7.342
Average
1.769
Median
Price to Book Value Benchmarks
| Phio Pharmaceuticals Corp | 0.6391 |
| Ocular Therapeutix Inc | 2.354 |
| Alpine Immune Sciences Inc | 13.40 |
| Scholar Rock Holding Corp | 5.317 |
| RAPT Therapeutics Inc | 1.091 |
Price to Book Value Related Metrics
| Price | 0.9085 |
| Earnings Yield | -75.95% |
| Market Cap | 152.57M |